HMGR catalyzes the rate-limiting step of the mevalonate pathway that leads to cholesterol biosynthesis; thus, inhibition of its enzymatic activity plays a significant role in lowering endogenous cholesterol levels during hypercholesterolemia [35]. Here, HMGA1 is linked to familial hypercholesterolemia.